Scilex Holding (SCLX) FCF Margin (2022 - 2026)
Scilex Holding (SCLX) recorded quarterly FCF Margin of 10.47% in Q1 2026, up 102.9% quarter-over-quarter from 360.97% in Q4 2025, and down 10967.0% on a YoY basis from N/an in Q1 2025.
Scilex Holding (SCLX) FCF Margin (2022 - 2026) Analysis & Trends
Scilex Holding's FCF Margin history runs 5 years deep, the most recent figure standing at 10.47% for Q1 2026.
- In Q1 2026, FCF Margin fell 10967.0% year-over-year to 10.47%; the TTM figure through Mar 2026 stood at 3.81% (down 3529.0% YoY), while the FY2025 annual figure was 12.16%, down 2204.0% from the prior year.
- FCF Margin was 10.47% for Q1 2026 at Scilex Holding, up from 360.97% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 120.14% in Q1 2025 to a low of 360.97% in Q4 2025.
- Historically, FCF Margin has averaged 22.8% across 5 years, with a median of 14.12% in 2024.
- The sharpest annual moves came in 2024 and 2025: FCF Margin surged 15946 bps in 2024, then plunged 37798 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 6.08% in 2022, then tumbled by 558 bps to 40.05% in 2023, then surged by 142 bps to 17.01% in 2024, then tumbled by 2223 bps to 360.97% in 2025, then surged by 103 bps to 10.47% in 2026.
- The last three FCF Margin figures came in at 10.47% (Q1 2026), 360.97% (Q4 2025), and 77.53% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | 20.59% |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | 15.19% |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 6.09% |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | 23.76% |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | 17.97% |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 17.14% |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 34.87% |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 93.16% |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | 6.59% |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn | 10.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.47% |
| Dec 31, 2025 | -360.97% |
| Sep 30, 2025 | 77.53% |
| Jun 30, 2025 | 71.68% |
| Mar 31, 2025 | 120.14% |
| Dec 31, 2024 | 17.01% |
| Sep 30, 2024 | 35.42% |
| Jun 30, 2024 | 14.12% |
| Mar 31, 2024 | 86.28% |
| Dec 31, 2023 | -40.05% |
| Sep 30, 2023 | 58.11% |
| Jun 30, 2023 | -107.08% |
| Mar 31, 2023 | -73.18% |
| Dec 31, 2022 | -6.08% |
| Sep 30, 2022 | 22.20% |
| Jun 30, 2022 | -155.63% |
| Mar 31, 2022 | -157.53% |